Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa.

Literature DB >> 23328091

Associations between HLA-DRB10102, HLA-B5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa.

Elizabeth Phillips, John A Bartlett, Ian Sanne, Michael M Lederman, John Hinkle, Franck Rousseau, David Dunn, Rebecca Pavlos, Ian James, Simon A Mallal, David W Haas.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2013 PMID： 23328091 PMCID： PMC3551216 DOI： 10.1097/QAI.0b013e31827ca50f

Source DB: PubMed Journal: J Acquir Immune Defic Syndr ISSN： 1525-4135 Impact factor: 3.731

× No keyword cloud information.

9 in total

1. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.

Authors: Hiroyuki Gatanaga; Hirohisa Yazaki; Junko Tanuma; Miwako Honda; Ikumi Genka; Katsuji Teruya; Natsuo Tachikawa; Yoshimi Kikuchi; Shinichi Oka
Journal: AIDS Date: 2007-01-11 Impact factor: 4.177

2. Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.

Authors: David W Haas; John A Bartlett; Janet W Andersen; Ian Sanne; Grant R Wilkinson; John Hinkle; Franck Rousseau; Christiana D Ingram; Audrey Shaw; Michael M Lederman; Richard B Kim
Journal: Clin Infect Dis Date: 2006-08-15 Impact factor: 9.079

3. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.

Authors: Ian Sanne; Herve Mommeja-Marin; John Hinkle; John A Bartlett; Michael M Lederman; Gary Maartens; Charles Wakeford; Audrey Shaw; Joseph Quinn; Robert G Gish; Franck Rousseau
Journal: J Infect Dis Date: 2005-02-10 Impact factor: 5.226

4. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

Authors: S Mallal; D Nolan; C Witt; G Masel; A M Martin; C Moore; D Sayer; A Castley; C Mamotte; D Maxwell; I James; F T Christiansen
Journal: Lancet Date: 2002-03-02 Impact factor: 79.321

5. Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent.

Authors: Jing Yuan; Sheng Guo; David Hall; Anna M Cammett; Supriya Jayadev; Manuel Distel; Stephen Storfer; Zimei Huang; Piroon Mootsikapun; Kiat Ruxrungtham; Daniel Podzamczer; David W Haas
Journal: AIDS Date: 2011-06-19 Impact factor: 4.177

6. HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients.

Authors: Roberto Littera; Carlo Carcassi; Alessandro Masala; Paola Piano; Paolo Serra; Francesco Ortu; Nicoletta Corso; Basilia Casula; Giorgio La Nasa; Licinio Contu; Paolo Emilio Manconi
Journal: AIDS Date: 2006-08-01 Impact factor: 4.177

7. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.

Authors: Annalise M Martin; David Nolan; Ian James; Paul Cameron; Jean Keller; Corey Moore; Elizabeth Phillips; Frank T Christiansen; Simon Mallal
Journal: AIDS Date: 2005-01-03 Impact factor: 4.177

8. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors: Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal: Proc Natl Acad Sci U S A Date: 2005-03-02 Impact factor: 11.205

9. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.

Authors: Soranun Chantarangsu; Taisei Mushiroda; Surakameth Mahasirimongkol; Sasisopin Kiertiburanakul; Somnuek Sungkanuparph; Weerawat Manosuthi; Woraphot Tantisiriwat; Angkana Charoenyingwattana; Thanyachai Sura; Wasun Chantratita; Yusuke Nakamura
Journal: Pharmacogenet Genomics Date: 2009-02 Impact factor: 2.089

9 in total

23 in total

Review 1. Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to 'de-labeling'.

Authors: Jason Trubiano; Elizabeth Phillips
Journal: Curr Opin Infect Dis Date: 2013-12 Impact factor: 4.915

Review 2. Pharmacogenomics of antimicrobial agents.

Authors: Ar Kar Aung; David W Haas; Todd Hulgan; Elizabeth J Phillips
Journal: Pharmacogenomics Date: 2014 Impact factor: 2.533

Review 3. Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors: Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal: Pharmacol Ther Date: 2019-01-22 Impact factor: 12.310

Review 4. Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbidities.

Authors: David W Haas; Philip E Tarr
Journal: Curr Opin HIV AIDS Date: 2015-03 Impact factor: 4.283

5. Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets.

Authors: Andrzej Bienczak; Paolo Denti; Adrian Cook; Lubbe Wiesner; Veronica Mulenga; Cissy Kityo; Addy Kekitiinwa; Diana M Gibb; David Burger; Ann S Walker; Helen McIlleron
Journal: AIDS Date: 2017-04-24 Impact factor: 4.177